189 related articles for article (PubMed ID: 9058411)
1. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.
Stanwood GD; McElligot S; Lu L; McGonigle P
Neurosci Lett; 1997 Feb; 223(1):13-6. PubMed ID: 9058411
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
Booze RM; Wallace DR
Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
[TBL] [Abstract][Full Text] [Related]
3. Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
Vessotskie JM; Kung MP; Chumpradit S; Kung HF
Brain Res; 1997 Dec; 778(1):89-98. PubMed ID: 9462880
[TBL] [Abstract][Full Text] [Related]
4. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
Burris KD; Filtz TM; Chumpradit S; Kung MP; Foulon C; Hensler JG; Kung HF; Molinoff PB
J Pharmacol Exp Ther; 1994 Feb; 268(2):935-42. PubMed ID: 8114008
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Hillefors M; von Euler G
Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
[TBL] [Abstract][Full Text] [Related]
6. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
Kung MP; Chumpradit S; Frederick D; Garner S; Burris KD; Molinoff PB; Kung HF
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):611-7. PubMed ID: 7708118
[TBL] [Abstract][Full Text] [Related]
7. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography.
Landwehrmeyer B; Mengod G; Palacios JM
Eur J Neurosci; 1993 Feb; 5(2):145-53. PubMed ID: 8261096
[TBL] [Abstract][Full Text] [Related]
8. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.
Flores G; Barbeau D; Quirion R; Srivastava LK
J Neurosci; 1996 Mar; 16(6):2020-6. PubMed ID: 8604046
[TBL] [Abstract][Full Text] [Related]
9. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
Murray AM; Ryoo HL; Gurevich E; Joyce JN
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11271-5. PubMed ID: 7972046
[TBL] [Abstract][Full Text] [Related]
10. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
11. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja.
Gurevich EV; Himes JW; Joyce JN
J Pharmacol Exp Ther; 1999 Apr; 289(1):587-98. PubMed ID: 10087054
[TBL] [Abstract][Full Text] [Related]
12. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
Wallace DR; Booze RM
J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
[TBL] [Abstract][Full Text] [Related]
13. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
Stanwood GD; Artymyshyn RP; Kung MP; Kung HF; Lucki I; McGonigle P
J Pharmacol Exp Ther; 2000 Dec; 295(3):1223-31. PubMed ID: 11082459
[TBL] [Abstract][Full Text] [Related]
14. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.
Jansson A; Goldstein M; Tinner B; Zoli M; Meador-Woodruff JH; Lew JY; Levey AI; Watson S; Agnati LF; Fuxe K
Neuroscience; 1999 Mar; 89(2):473-89. PubMed ID: 10077329
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding.
Schambra UB; Duncan GE; Breese GR; Fornaretto MG; Caron MG; Fremeau RT
Neuroscience; 1994 Sep; 62(1):65-85. PubMed ID: 7816213
[TBL] [Abstract][Full Text] [Related]
16. Differential visualization of dopamine D2 and D3 receptors in rat brain.
Parsons B; Stanley M; Javitch J
Eur J Pharmacol; 1993 Apr; 234(2-3):269-72. PubMed ID: 8097723
[TBL] [Abstract][Full Text] [Related]
17. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
[TBL] [Abstract][Full Text] [Related]
18. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors.
Levant B; Grigoriadis DE; De Souza EB
Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161
[TBL] [Abstract][Full Text] [Related]
19. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
[TBL] [Abstract][Full Text] [Related]
20. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.
Le Moine C; Bloch B
Neuroscience; 1996 Jul; 73(1):131-43. PubMed ID: 8783237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
